Cadila News
Cadila Healthcare was reconsidered by the FIPB following the changes made by the government in foreign direct investment (FDI) policy last month.
Pharma firm Cadila Healthcare Ltd posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second quarter ended on September 30, 2015-16.
With this approval, the group has received 100 approvals and has so far filed 260 ANDAs (abbreviated new drug applications).
Zydus BSV Pharma, founded in 2005, is a joint venture (JV) company of Cadila Healthcare and biotech firm Bharat Serums and Vaccines (BSV).
Drug firm Cadila Healthcare is voluntarily recalling 19,536 bottles of benzonatate capsules, used to treat coughs, in the US due to "wet and/or leaking capsules".
Cadila Healthcare is voluntarily recalling 15,144 bottles of its anti-hypertension drug Amlodipine Besylate tablets in the US market, according to the USFDA.
Drug firm Cadila Healthcare is voluntarily recalling 5,400 bottles of anti-hypertension drug Atenolol tablets, in the US for failing to meet specifications.
Loading...